EUVIMEDEUVIMED entdecken
Crossref

Effects of Gynecomastia Surgery on Readiness and Return to Duty in an Active Duty Military Population

Bobby Zhang iD, Brendan Podszus, James Williams, Hannah Palmerton, Grace Pak, Erik Roedel, Jason Bingham, John McClellan

Military Medicine · 2024

DOI: 10.1093/milmed/usad452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2024. Verfasst von Bobby Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Madigan Army Medical Center, Tacoma, WA 98431, USA. Hauptthemen laut MEDLINE: Gynecomastia, Military Personnel, Return to Work. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Simple mastectomies are routinely performed in the military health care system as gynecomastia can cause significant pain and discomfort when wearing body armor. Postoperative recovery negatively impacts personnel readiness. In this study, we sought to study time to return to duty in active duty service members who undergo surgery for gynecomastia. Methods and Materials We conducted a single-center retrospective review of active duty patients undergoing a surgical operation for gynecomastia from July 2020—June 2022. A total of 96 patients were included. Our primary outcome of interest was time from surgery to return to duty. A multivariate analysis was performed to assess for factors independently associated with surgical complications including patient demographics and operative techniques.

Results

The median number of days to return to duty after surgery was 28 days (IQR 13-37). The median loss of duty days because of gynecomastia without surgery was 19 days (IQR 10-21), which was different on the Mann–Whitney U test. Surgical complications were observed in 19 patients (19.7%) with the most common complications being seroma (11), hematoma (4), nipple-areolar complex necrosis (2), and infection (2). Patients with a complication have significantly more time to return to duty (28 vs. 49 days, P < .001). Risk factors associated with an increased risk of complication include ranks E1-E4, behavioral health diagnosis, “open” vs. “combined” technique with liposuction, length of operation greater than 58 minutes, and excised breast mass greater than 17.9 g.

Conclusions

Gynecomastia surgery is associated with a detriment to personnel readiness. Surgery should be reserved for patients with severe symptoms that prevent the performance of daily duties. Furthermore, factors associated with an increased risk for complications include ranks E1-E5, behavioral health diagnosis, length of operation >58 minutes, and excised breast mass >17.9 g. The operating surgeon should be mindful of these factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GynecomastiaMilitary PersonnelReturn to WorkAdultHumansMaleMastectomyMultivariate AnalysisPostoperative ComplicationsRetrospective Studies

Autor:innen und Institutionen

  • Department of General Surgery, Madigan Army Medical Center, Tacoma, WA 98431, USA.
  • School of Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA.

ORCID-Profile: Bobby Zhang

Zitieren

APA

Zhang, B., Podszus, B., Williams, J., Palmerton, H., Pak, G., Roedel, E., Bingham, J., & McClellan, J. (2024). Effects of Gynecomastia Surgery on Readiness and Return to Duty in an Active Duty Military Population. Military Medicine. https://doi.org/10.1093/milmed/usad452

Vancouver

Zhang B, Podszus B, Williams J, Palmerton H, Pak G, Roedel E, et al. Effects of Gynecomastia Surgery on Readiness and Return to Duty in an Active Duty Military Population. Military Medicine. 2024. doi:10.1093/milmed/usad452

BibTeX
@article{Zhang2024,
  author = {Zhang, Bobby and Podszus, Brendan and Williams, James and Palmerton, Hannah and Pak, Grace and Roedel, Erik and Bingham, Jason and McClellan, John},
  title = {Effects of Gynecomastia Surgery on Readiness and Return to Duty in an Active Duty Military Population},
  journal = {Military Medicine},
  year = {2024},
  doi = {10.1093/milmed/usad452}
}
Kostenlos starten →